Top compounds associated with response to TRIM16L


Feature Type Standardized
Nominal ANOVA
mRNA IPR-456 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.038 0.3
mRNA BRD1835 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC -0.059 0.3
mRNA purmorphamine CTRPv2 pan-cancer AAC -0.04 0.3
mRNA BRD-K35604418 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA canertinib CTRPv2 pan-cancer AAC -0.038 0.3
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.043 0.3
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
Download CSV